Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print December 19, 2007, doi:10.1212/01.wnl.0000284828.84464.35)
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
01.wnl.0000284828.84464.35v1
70/10/748    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henneke, M.
Right arrow Articles by Gärtner, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henneke, M.
Right arrow Articles by Gärtner, J.
Related Collections
Right arrow Leukodystrophies
Right arrow All Pediatric
Right arrow Developmental disorders
Right arrow All Genetics
NEUROLOGY 2008;70:748-754
© 2008 American Academy of Neurology

GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease

M. Henneke, MD, P. Combes, MS, S. Diekmann, MS, E. Bertini, MD, K. Brockmann, MD, A. P. Burlina, MD, PhD, J. Kaiser, BS, A. Ohlenbusch, PhD, B. Plecko, MD, D. Rodriguez, MD, PhD, O. Boespflug-Tanguy, MD, PhD and J. Gärtner, MD

From the Department of Pediatrics and Pediatric Neurology (M.H., S.D., K.B., J.K., A.O., J.G.), Georg August University, Göttingen, Germany; INSERM, Université d’Auvergne, UMR 384, Faculté de Médecine Clermont-Ferrand, and CHU Clermont-Ferrand, Department of Human Genetics (P.C., O.B.-T.), University Hospital, Clermont-Ferrand, France; Department of Molecular Medicine (E.B.), Ospedale Pediatrico Bambino Gesu, Scientific Institute, IRCCS, Rome, Italy; Department of Neuroscience (A.P.B.), Neurological Clinic, University Hospital, Padua, Italy; Department of General Pediatrics (B.P.), University of Graz, Austria; and INSERM, UMR 546, Université Paris Pitié Salpétrière, and AP-HP, Department of Pediatric Neurology (D.R.), Hopital A. Trousseau, Paris, France.

Address correspondence and reprint requests to Dr. Jutta Gärtner, Department of Pediatrics and Pediatric Neurology, Georg August University, Faculty of Medicine, Robert-Koch-Strasse 40, 37075 Göttingen, Germany gaertnj{at}med.uni-goettingen.de

Background: Pelizaeus-Merzbacher-like disease (PMLD) is a genetically heterogeneous disorder within the group of hypomyelinating leukoencephalopathies. Mutations of the gap junction protein {alpha}12 (GJA12) gene are known to cause one autosomal recessive PMLD form. Few patients with GJA12 mutated PMLD have been reported, and to date, the frequency as well as the genotypic and phenotypic spectrum of GJA12 related PMLD is unclear.

Methods: We report mutation analysis of the GJA12 gene in a clinical and radiologic well-characterized multiethnic cohort of 193 patients with PMLD from 182 families.

Results and Conclusions: Only 16 patients (8.3%) from 14 families (7.7%) carry GJA12 mutations including five families where we detected only one mutated allele. Among those, we identified 11 novel alterations. Thus, GJA12 mutations are a rather rare cause for Pelizaeus-Merzbacher-like disease. The clinical phenotype of patients with a GJA12 mutation was evaluated and is overall comparable to the clinical features seen in mild forms of proteolipid protein 1 (PLP1) related disorder but with better cognition and earlier signs of axonal degeneration.

Abbreviations: PMLD = Pelizaeus-Merzbacher-like disease; SPG = spastic paraplegia.


Editorial, page 744

e-Pub ahead of print on December 19, 2007, at www.neurology.org.

*These authors contributed equally to this study.

Supported by the Deutsche Forschungsgemeinschaft, grant number GA 354/6-1 (J.G. and M.H.), the European Leukodystrophy Association (P.C. and O.B.-T.), and the Jean-Pierre and Nancy Boespflug myopathic research foundation (P.C. and O.B.-T.).

Disclosure: The authors report no conflicts of interest.

Received February 17, 2007. Accepted in final form June 13, 2007.




This article has been cited by other articles:


Home page
J Child NeurolHome page
A. Fattal-Valevski, M. S. DiMaio, F. M. Hisama, G. M. Hobson, A. Davis-Williams, J. Y. Garbern, M. J. Mahoney, E. H. Kolodny, and G. M. Pastores
Variable Expression of a Novel PLP1 Mutation in Members of a Family With Pelizaeus-Merzbacher Disease
J Child Neurol, May 1, 2009; 24(5): 618 - 624.
[Abstract] [PDF]


Home page
BrainHome page
J. L. Orthmann-Murphy, E. Salsano, C. K. Abrams, A. Bizzi, G. Uziel, M. M. Freidin, E. Lamantea, M. Zeviani, S. S. Scherer, and D. Pareyson
Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations
Brain, February 1, 2009; 132(2): 426 - 438.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. Mar and M. J. Noetzel
Gap junction protein 12: "Connexing" the pieces in the puzzle of myelination and leukodystrophy
Neurology, March 4, 2008; 70(10): 744 - 745.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by AAN Enterprises, Inc.